13F Data
13F filer · CIK 1615982

Venrock Adviser, LLC

NEW YORK, NY · filing since Q1 2020 · last filing Aug 14, 2026
Reported value
$3.3B
+$618.9M vs prior
Positions
33
New / sold out
4 / 4
Added / reduced
5 / 5
Turnover
3.3%
buys $97.7M · sells $368.9M
Top-10 weight
80.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedERASCA INC+1,509,000+9.2%+$27.6M
NewACHIEVE LIFE SCIENCE INC+2,751,032–+$18.0M
NewPARABILIS MEDICINES INC+625,000–+$17.1M
AddedRELMADA THERAPEUTICS INC+2,000,925+41.3%+$13.8M
AddedX4 PHARMACEUTICALS INC+1,603,728+485.2%+$7.5M
AddedSAVARA INC+1,005,568+7.3%+$6.2M
AddedARTIVA BIOTHERAPEUTICS INC+434,027+27.0%+$4.2M
NewRESEARCH ALLIANCE CORP III+300,000–+$3.2M
NewINMED PHARMACEUTICALS INC+32,685–+$50.7K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outKALVISTA PHARMACEUTICALS INC-6,474,485-100.0%$-130.3M
ReducedSPYRE THERAPEUTICS INC-700,000-19.0%$-62.1M
ReducedENLIVEN THERAPEUTICS INC-1,200,000-69.5%$-60.9M
Sold outENGENE HOLDINGS INC-4,771,414-100.0%$-32.5M
Sold outTENAX THERAPEUTICS INC-1,675,262-100.0%$-26.8M
ReducedCYTOMX THERAPEUTICS INC-5,000,000-50.1%$-18.8M
ReducedCOGENT BIOSCIENCES INC-357,834-17.9%$-13.8M
Sold outSEPTERNA INC-506,056-100.0%$-12.2M
ReducedVIRIDIAN THERAPEUTICS INC-624,792-16.1%$-11.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q1 2020: $369.2MQ2 2020: $417.6MQ3 2020: $511.2MQ4 2020: $680.1MQ1 2021: $921.8MQ2 2021: $824.4MQ3 2021: $778.5MQ4 2021: $731.5MQ1 2022: $617.2MQ2 2022: $507.8MQ3 2022: $648.1MQ4 2022: $593.6MQ1 2023: $512.2MQ2 2023: $625.4MQ3 2023: $949.9MQ4 2023: $1.5BQ1 2024: $2.1BQ2 2024: $1.6BQ3 2024: $1.9BQ4 2024: $1.5BQ1 2025: $1.2BQ2 2025: $1.3BQ3 2025: $1.8BQ4 2025: $2.0BQ1 2026: $2.7BQ2 2026: $3.3B
Q1 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1APOGEE THERAPEUTICS INCCOM8,493,321$1.1B34.18%
2ORUKA THERAPEUTICS INCCOM4,148,428$394.8M11.97%
3ERASCA INCCOM17,891,812$327.8M9.94%
4SPYRE THERAPEUTICS INCCOM NEW2,985,448$265.0M8.04%
5DIANTHUS THERAPEUTICS INCCOM1,180,000$115.0M3.49%
6OCULAR THERAPEUTIX INCCOM10,346,926$101.6M3.08%
7DAMORA THERAPEUTICS INCCOM NEW3,603,595$93.7M2.84%
8SAVARA INCCOM14,745,943$90.8M2.75%
9JADE BIOSCIENCES INCCOM NEW3,220,364$71.6M2.17%
10COGENT BIOSCIENCES INCCOM1,642,166$63.6M1.93%
23 more rows. Subscribe for $29/month to see every row, download the data and use the API.